Cite
Topical Ruxolitinib in the Management of Frontal Fibrosing Alopecia and/or Lichen Planopilaris: A Single-center Retrospective Cohort Study.
MLA
Williams, Kimberly N., et al. “Topical Ruxolitinib in the Management of Frontal Fibrosing Alopecia and/or Lichen Planopilaris: A Single-Center Retrospective Cohort Study.” Journal of the American Academy of Dermatology, Sept. 2024. EBSCOhost, https://doi.org/10.1016/j.jaad.2024.09.032.
APA
Williams, K. N., Perez, S. M., Burroway, B., & Tosti, A. (2024). Topical Ruxolitinib in the Management of Frontal Fibrosing Alopecia and/or Lichen Planopilaris: A Single-center Retrospective Cohort Study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2024.09.032
Chicago
Williams, Kimberly N, Sofia M Perez, Brandon Burroway, and Antonella Tosti. 2024. “Topical Ruxolitinib in the Management of Frontal Fibrosing Alopecia and/or Lichen Planopilaris: A Single-Center Retrospective Cohort Study.” Journal of the American Academy of Dermatology, September. doi:10.1016/j.jaad.2024.09.032.